RecruitingNot ApplicableNCT07123987

Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia


Sponsor

Mohamed Hosny Ismail Easa

Enrollment

34 participants

Start Date

Sep 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the therapeutic efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in the treatment of patients with post-herpetic neuralgia (PHN). Participants will receive taVNS in addition to standard care. The study aims to determine whether taVNS can provide significant pain relief and improve quality of life in PHN patients.


Eligibility

Min Age: 35 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying traditional medical treatment for PHN and a medical device called transcutaneous auricular vagus nerve stimulation (taVNS) for people with post-herpetic neuralgia (phn).. The study is currently recruiting participants at 1 location. People eligible for this study include aged 35 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscutaneous auricular vagus nerve stimulation (taVNS)

Use of the EV-906 device with TENS ear clips for transcutaneous auricular vagus nerve stimulation (taVNS), applied according to the study protocol, in addition to standard medical treatment for post-herpetic neuralgia. This device meets ISO 13485, FDA QSR, and CE standards

OTHERtraditional medical treatment for PHN

Standard medical treatment for post-herpetic neuralgia as per current clinical guidelines, without the application of taVNS device.


Locations(1)

Faculty of Physical Therapy - Cairo University

Cairo, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07123987


Related Trials